{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T09:01:39Z","timestamp":1784710899506,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100011082","name":"School of Medicine, University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","award":["Physician in training Program"],"award-info":[{"award-number":["Physician in training Program"]}],"id":[{"id":"10.13039\/100011082","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s12028-022-01579-z","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T17:08:09Z","timestamp":1662570489000},"page":"41-51","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Association of Serum Pyridoxal Phosphate Levels with Established Status Epilepticus"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1680-2302","authenticated-orcid":false,"given":"Clio","family":"Rubinos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jose","family":"Bruzzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Blodgett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puja","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Hianik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Jadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordane","family":"Boudesseul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey","family":"Olm-Shipman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Meeker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence J.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,7]]},"reference":[{"issue":"10","key":"1579_CR1","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/epi.13121","volume":"56","author":"E Trinka","year":"2015","unstructured":"Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus - report of the ILAE task force on classification of status epilepticus. Epilepsia. 2015;56(10):1515\u201323. https:\/\/doi.org\/10.1111\/epi.13121.","journal-title":"Epilepsia"},{"issue":"6","key":"1579_CR2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S1474-4422(15)00042-3","volume":"14","author":"JP Betjemann","year":"2015","unstructured":"Betjemann JP, Lowenstein DH. Status epilepticus in adults. Lancet Neurol. 2015;14(6):615\u201324. https:\/\/doi.org\/10.1016\/S1474-4422(15)00042-3.","journal-title":"Lancet Neurol"},{"issue":"7","key":"1579_CR3","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1056\/NEJMoa1107494","volume":"366","author":"R Silbergleit","year":"2012","unstructured":"Silbergleit R, Durkalski V, Lowenstein D, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012;366(7):591\u2013600. https:\/\/doi.org\/10.1056\/NEJMoa1107494.","journal-title":"N Engl J Med"},{"issue":"9","key":"1579_CR4","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMoa002141","volume":"345","author":"BK Alldredge","year":"2001","unstructured":"Alldredge BK, Gelb AM, Marshal Isaacs S, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001;345(9):631\u20137. https:\/\/doi.org\/10.1056\/NEJMoa002141.","journal-title":"N Engl J Med"},{"issue":"16","key":"1579_CR5","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1001\/jama.2014.2625","volume":"311","author":"JM Chamberlain","year":"2014","unstructured":"Chamberlain JM, Okada P, Holsti M, et al. Lorazepam vs diazepam for pediatric status epilepticus: a randomized clinical trial. JAMA - J Am Med Assoc. 2014;311(16):1652\u201360. https:\/\/doi.org\/10.1001\/jama.2014.2625.","journal-title":"JAMA - J Am Med Assoc"},{"issue":"22","key":"1579_CR6","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1905795","volume":"381","author":"J Kapur","year":"2019","unstructured":"Kapur J, Elm J, Chamberlain JM, et al. Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med. 2019;381(22):2103\u201313. https:\/\/doi.org\/10.1056\/NEJMoa1905795.","journal-title":"N Engl J Med"},{"issue":"3","key":"1579_CR7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/jp.2008.180","volume":"29","author":"L Valle-Morales","year":"2009","unstructured":"Valle-Morales L, Cort\u00e9s-Cros E, Santana A, Barber M, Figueras T, Garc\u00eda-Hern\u00e1ndez J\u00c1. Epileptic status refractory to conventional treatment caused by vitamin B6 deficiency. J Perinatol. 2009;29(3):252\u20133. https:\/\/doi.org\/10.1038\/jp.2008.180.","journal-title":"J Perinatol"},{"issue":"1","key":"1579_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.0013-9580.2004.00703.x","volume":"45","author":"A Schulze-Bonhage","year":"2004","unstructured":"Schulze-Bonhage A, Kurthen M, Walger P, Elger CE. Pharmacorefractory status epilepticus due to low vitamin B6 levels during pregnancy. Epilepsia. 2004;45(1):81\u20134. https:\/\/doi.org\/10.1111\/j.0013-9580.2004.00703.x.","journal-title":"Epilepsia"},{"key":"1579_CR9","unstructured":"Romero JA, Kuczler FJ. Isoniazid overdose: recognition and management. Am Fam Physician. 1998;57(4):749\u2013752. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9490997. Accessed March 20, 2020."},{"issue":"2","key":"1579_CR10","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1177\/0148607110384118","volume":"35","author":"AT Gerlach","year":"2011","unstructured":"Gerlach AT, Thomas S, Stawicki SP, Whitmill ML, Steinberg SM, Cook CH. Vitamin B 6 deficiency: a potential cause of refractory seizures in adults. J Parenter Enter Nutr. 2011;35(2):272\u20135. https:\/\/doi.org\/10.1177\/0148607110384118.","journal-title":"J Parenter Enter Nutr"},{"key":"1579_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.yebeh.2015.08.015","volume":"52","author":"HN Dave","year":"2015","unstructured":"Dave HN, Eugene Ramsay R, Khan F, Sabharwal V, Irland M. Pyridoxine deficiency in adult patients with status epilepticus. Epilepsy Behav. 2015;52:154\u20138. https:\/\/doi.org\/10.1016\/j.yebeh.2015.08.015.","journal-title":"Epilepsy Behav"},{"issue":"2","key":"1579_CR12","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3945\/ajcn.113.082008","volume":"100","author":"M Albersen","year":"2014","unstructured":"Albersen M, Bosma M, Luykx JJ, et al. Vitamin B-6 vitamers in human plasma and cerebrospinal fluid. Am J Clin Nutr. 2014;100(2):587\u201392. https:\/\/doi.org\/10.3945\/ajcn.113.082008.","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"1579_CR13","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/ajcn\/87.5.1446","volume":"87","author":"MS Morris","year":"2008","unstructured":"Morris MS, Picciano MF, Jacques PF, Selhub J. Plasma pyridoxal 5\u2032-phosphate in the US population: the national health and nutrition examination survey, 2003\u20132004. Am J Clin Nutr. 2008;87(5):1446\u201354. https:\/\/doi.org\/10.1093\/ajcn\/87.5.1446.","journal-title":"Am J Clin Nutr"},{"key":"1579_CR14","doi-asserted-by":"publisher","unstructured":"Leklem JE (1990) Vitamin status report. J Nutr 120: 1503\u20131507. doi: https:\/\/doi.org\/10.1093\/jn\/120.suppl_11.1503","DOI":"10.1093\/jn\/120.suppl_11.1503"},{"issue":"4","key":"1579_CR15","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/ajcn\/43.4.599","volume":"43","author":"JA Driskell","year":"1986","unstructured":"Driskell JA, Moak SW. Plasma pyridoxal phosphate concentrations and coenzyme stimulation of erythrocyte alanine aminotransferase activities of white and black adolescent girls. Am J Clin Nutr. 1986;43(4):599\u2013603. https:\/\/doi.org\/10.1093\/ajcn\/43.4.599.","journal-title":"Am J Clin Nutr"},{"key":"1579_CR16","volume-title":"Modern nutrition in health and disease","author":"A Mackey","year":"2005","unstructured":"Mackey A, Davis S, Gregory J. Vitamin B6. In: Shike M, Ross A, Caballero B, Cousins R, editors. Modern nutrition in health and disease. Lippincott Williams & Wilkins; 2005."},{"issue":"7624","key":"1579_CR17","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/BMJ.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ Br Med J. 2007;335(7624):806. https:\/\/doi.org\/10.1136\/BMJ.39335.541782.AD.","journal-title":"BMJ Br Med J"},{"key":"1579_CR18","unstructured":"Gaby AR. Natural approaches to epilepsy - PubMed. Altern Med Rev. 2007;12(1):9\u201324. https:\/\/pubmed.ncbi.nlm.nih.gov\/17397265\/. Accessed March 23, 2022."},{"key":"1579_CR19","doi-asserted-by":"publisher","first-page":"100452","DOI":"10.1016\/j.ebr.2021.100452","volume":"16","author":"E Dreischmeier","year":"2021","unstructured":"Dreischmeier E, Zuloaga A, Kotloski RJ, Karasov AO, Gidal BE. Levetiracetam-associated irritability and potential role of vitamin B6 use in veterans with epilepsy. Epilepsy Behav Reports. 2021;16:100452. https:\/\/doi.org\/10.1016\/j.ebr.2021.100452.","journal-title":"Epilepsy Behav Reports"},{"key":"1579_CR20","doi-asserted-by":"crossref","unstructured":"Mahmoud A, Tabassum S, Al Enazi S, et al (2021) Amelioration of Levetiracetam Induced Behavioral Side Effects by Pyridoxine A Randomized Double Blind Controlled Study. Pediatr Neurol. 119: 15\u201321","DOI":"10.1016\/j.pediatrneurol.2021.02.010"},{"issue":"3","key":"1579_CR21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.yebeh.2012.04.132","volume":"24","author":"S Mintzer","year":"2012","unstructured":"Mintzer S, Skidmore CT, Sperling MR. B-vitamin deficiency in patients treated with antiepileptic drugs. Epilepsy Behav. 2012;24(3):341\u20134. https:\/\/doi.org\/10.1016\/j.yebeh.2012.04.132.","journal-title":"Epilepsy Behav"},{"key":"1579_CR22","doi-asserted-by":"publisher","unstructured":"Wood JD (1975) The role of \u03b3-aminobutyric acid in the mechanism of seizures. Prog Neurobiol. 5: 77\u201395. doi:https:\/\/doi.org\/10.1016\/0301-0082(75)90008-8","DOI":"10.1016\/0301-0082(75)90008-8"},{"issue":"6","key":"1579_CR23","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1111\/j.1471-4159.1972.tb05097.x","volume":"19","author":"JD Wood","year":"1972","unstructured":"Wood JD, Peesker SJ. The effect on gaba metabolism in brain of isonicotinic acid hydrazide and pyridoxine as a function of time after administration. J Neurochem. 1972;19(6):1527\u201337. https:\/\/doi.org\/10.1111\/j.1471-4159.1972.tb05097.x.","journal-title":"J Neurochem"},{"key":"1579_CR24","unstructured":"Gospe SM. Pyridoxine-Dependent Epilepsy. University of Washington, Seattle; 1993. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20301659. Accessed October 12, 2020."},{"key":"1579_CR25","doi-asserted-by":"publisher","DOI":"10.1592\/phco.26.10.1529","author":"LE Morrow","year":"2006","unstructured":"Morrow LE, Wear RE, Schuller D, Malesker M. Acute isoniazid toxicity and the need for adequate pyridoxine supplies. Pharmacotherapy. 2006. https:\/\/doi.org\/10.1592\/phco.26.10.1529.","journal-title":"Pharmacotherapy"},{"issue":"1","key":"1579_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.14581\/jer.15006","volume":"5","author":"D-G Lee","year":"2015","unstructured":"Lee D-G, Lee Y, Shin H, et al. Seizures related to vitamin B6 deficiency in adults. J Epilepsy Res. 2015;5(1):23\u20134. https:\/\/doi.org\/10.14581\/jer.15006.","journal-title":"J Epilepsy Res"},{"issue":"2","key":"1579_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00702-012-0856-1","volume":"120","author":"S Skodda","year":"2013","unstructured":"Skodda S, M\u00fcller T. Refractory epileptic seizures due to vitamin B6 deficiency in a patient with Parkinson\u2019s disease under duodopa\u00ae therapy. J Neural Transm. 2013;120(2):315\u20138. https:\/\/doi.org\/10.1007\/s00702-012-0856-1.","journal-title":"J Neural Transm"},{"issue":"8","key":"1579_CR28","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/ajcn\/29.8.847","volume":"29","author":"CS Rose","year":"1976","unstructured":"Rose CS, Gyorgy P, Butler M, et al. Age differences in vitamin B6 status of 617 men. Am J Clin Nutr. 1976;29(8):847\u201353. https:\/\/doi.org\/10.1093\/ajcn\/29.8.847.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"1579_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/ajcn\/28.1.10","volume":"28","author":"RR Brown","year":"1975","unstructured":"Brown RR, Rose DP, Leklem JE, Linkswiler H, Anand R. Urinary 4 pyridoxic acid, plasma pyroxidal phosphate, and erythrocyte aminotransferase levels in oral contraceptive users receiving controlled intakes of vitamin B6. Am J Clin Nutr. 1975;28(1):10\u20139. https:\/\/doi.org\/10.1093\/ajcn\/28.1.10.","journal-title":"Am J Clin Nutr"},{"issue":"7","key":"1579_CR30","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/ajcn\/34.7.1328","volume":"34","author":"JB Tarr","year":"1981","unstructured":"Tarr JB, Tamura T, Stokstad ELR. Availability of vitamin B6 and pantothenate in an average American diet in man. Am J Clin Nutr. 1981;34(7):1328\u201337. https:\/\/doi.org\/10.1093\/ajcn\/34.7.1328.","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"1579_CR31","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/j.1749-6632.1990.tb28047.x","volume":"106","author":"A Lui","year":"1985","unstructured":"Lui A, Lumeng L, Aronoff G. Relationship between body store of vitamin B6 and plasma pyridoxal-P clearance: metabolic balance studies in humans. J Lab Clin Med. 1985;106(5):491\u20137. https:\/\/doi.org\/10.1111\/j.1749-6632.1990.tb28047.x.","journal-title":"J Lab Clin Med"},{"issue":"4","key":"1579_CR32","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0002-9343(02)01528-0","volume":"114","author":"EPI Chiang","year":"2003","unstructured":"Chiang EPI, Bagley PJ, Selhub J, Nadeau M, Roubenoff R. Abnormal vitamin B6 status is associated with severity of symptoms in patients with rheumatoid arthritis. Am J Med. 2003;114(4):283\u20137. https:\/\/doi.org\/10.1016\/S0002-9343(02)01528-0.","journal-title":"Am J Med"},{"issue":"1\u20132","key":"1579_CR33","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.eplepsyres.2012.03.002","volume":"101","author":"M Linnebank","year":"2012","unstructured":"Linnebank M, Moskau S, Semmler A, et al. Antiepileptic drugs and vitamin B6 plasma levels in adult patients. Epilepsy Res. 2012;101(1\u20132):182\u20134. https:\/\/doi.org\/10.1016\/j.eplepsyres.2012.03.002.","journal-title":"Epilepsy Res"},{"issue":"8","key":"1579_CR34","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1056\/NEJM198308253090801","volume":"309","author":"H Schaumburg","year":"1983","unstructured":"Schaumburg H, Kaplan J, Windebank A, et al. Sensory neuropathy from pyridoxine abuse: a new megavitamin syndrome. N Engl J Med. 1983;309(8):445\u20138. https:\/\/doi.org\/10.1056\/NEJM198308253090801.","journal-title":"N Engl J Med"},{"issue":"2","key":"1579_CR35","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.nmd.2007.09.009","volume":"18","author":"HJ Gdynia","year":"2008","unstructured":"Gdynia HJ, M\u00fcller T, Sperfeld AD, et al. Severe sensorimotor neuropathy after intake of highest dosages of vitamin B6. Neuromuscul Disord. 2008;18(2):156\u20138. https:\/\/doi.org\/10.1016\/j.nmd.2007.09.009.","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"1579_CR36","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1212\/wnl.42.7.1367","volume":"42","author":"AR Berger","year":"1992","unstructured":"Berger AR, Schaumburg HH, Schroeder C, Apfel S, Reynolds R. Dose response, coasting, and differential fiber vulnerability in human toxic neuropathy: a prospective study of pyridoxine neurotoxicity. Neurology. 1992;42(7):1367\u201370. https:\/\/doi.org\/10.1212\/wnl.42.7.1367.","journal-title":"Neurology"},{"issue":"11","key":"1579_CR37","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1007\/s10072-014-1902-6","volume":"35","author":"K Kulkantrakorn","year":"2014","unstructured":"Kulkantrakorn K. Pyridoxine-induced sensory ataxic neuronopathy and neuropathy: revisited. Neurol Sci. 2014;35(11):1827\u201330. https:\/\/doi.org\/10.1007\/s10072-014-1902-6.","journal-title":"Neurol Sci"},{"issue":"15","key":"1579_CR38","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1056\/NEJM198410113111513","volume":"311","author":"A Berger","year":"1984","unstructured":"Berger A, Schaumburg H. More on neuropathy from pyridoxine abuse. N Engl J Med. 1984;311(15):986\u20137. https:\/\/doi.org\/10.1056\/NEJM198410113111513.","journal-title":"N Engl J Med"},{"key":"1579_CR39","unstructured":"EFSA Scientific Committee on Food; Scientific Panel on Dietetic Products, Nutrition and Allergies; Tolerable Upper Intake Levels for vitamins and minerals. EFSA J. 2006. https:\/\/www.efsa.europa.eu\/sites\/default\/files\/efsa_rep\/blobserver_assets\/ndatolerableuil.pdf. Accessed June 11, 2021."},{"issue":"4","key":"1579_CR40","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/j.1528-1157.1993.tb00458.x","volume":"34","author":"J Pietz","year":"1993","unstructured":"Pietz J, Benninger C, Sch\u00e4fer H, Sontheimer D, Mittermaier G, Rating D. Treatment of infantile spasms with high-dosage vitamin B6. Epilepsia. 1993;34(4):757\u201363. https:\/\/doi.org\/10.1111\/j.1528-1157.1993.tb00458.x.","journal-title":"Epilepsia"},{"issue":"11","key":"1579_CR41","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1007\/s12098-010-0186-y","volume":"77","author":"D Mishra","year":"2010","unstructured":"Mishra D, Kalra V, Seth R, Gulati S, Saha N. Efficacy of pyridoxine in early-onset idiopathic intractable seizures in children. Indian J Pediatr. 2010;77(11):1252\u20136. https:\/\/doi.org\/10.1007\/s12098-010-0186-y.","journal-title":"Indian J Pediatr"},{"issue":"1","key":"1579_CR42","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0887-8994(97)00035-0","volume":"17","author":"FY Jiao","year":"1997","unstructured":"Jiao FY, Gao DY, Takuma Y, et al. Randomized, controlled trial of high-dose intravenous pyridoxine in the treatment of recurrent seizures in children. Pediatr Neurol. 1997;17(1):54\u20137. https:\/\/doi.org\/10.1016\/S0887-8994(97)00035-0.","journal-title":"Pediatr Neurol"},{"issue":"5","key":"1579_CR43","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1136\/ADC.81.5.431","volume":"81","author":"P Baxter","year":"1999","unstructured":"Baxter P. Epidemiology of pyridoxine dependent and pyridoxine responsiveseizures in the UK. Arch Dis Child. 1999;81(5):431. https:\/\/doi.org\/10.1136\/ADC.81.5.431.","journal-title":"Arch Dis Child"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-022-01579-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-022-01579-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-022-01579-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T22:54:08Z","timestamp":1676588048000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-022-01579-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1579"],"URL":"https:\/\/doi.org\/10.1007\/s12028-022-01579-z","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,7]]},"assertion":[{"value":"20 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No author declared any conflict of interest pertaining to this article, and all reported items pertain to outside of this work. Drs. Tsai, Jadav, Bruzzone, Olm-Shipman, Wilson, and Meeker and Mrs. Patel, Mrs. Hainik, and Mrs. Blodgett did not report any disclosures. Dr. Rubinos receives funding from the Physician in Training Program (UNC School of Medicine). Dr. Hirsch reports research support to Yale University for investigator-initiated studies from the Daniel Raymond Wong Neurology Research Fund at Yale; royalties from Wiley and Wolters-Kluwer; personal fees from Ceribell, Monteris, Neuropace, Aquestive, Medtronic, UCB, Marinus, Accure, Natus, Neurelis, and Eisai; and speaking honoraria from Neuropace, Natus, and UCB.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study adheres to ethical guidelines and has approval from the local institutional review board (UNC, IRB20-3089; Yale, IRB HIC#111109342), including waiver of consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}